This company has been marked as potentially delisted and may not be actively trading. Third Harmonic Bio (THRD) Institutional Ownership Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Third Harmonic Bio (NASDAQ:THRD)CurrentInstitutional OwnershipPercentage93.95%Number ofInstitutional Buyers(last 12 months)3TotalInstitutional Inflows(last 12 months)$555.05KNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$144.79K Get THRD Insider Trade Alerts Want to know when executives and insiders are buying or selling Third Harmonic Bio stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data THRD Institutional Buying and Selling by Quarter Third Harmonic Bio Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails6/27/2025Goldman Sachs Group Inc.157,974$548K0.0%+48.1%0.350% 4/17/2025FNY Investment Advisers LLC91,052$315K0.2%N/A0.202% 1/17/2025SG Americas Securities LLC12,050$124K0.0%-29.1%0.027% 10/3/2024SG Americas Securities LLC16,990$230K0.0%+31.7%0.041% 7/12/2024SG Americas Securities LLC12,904$168K0.0%-35.8%0.032% 5/7/2024SG Americas Securities LLC20,097$190K0.0%+62.9%0.049% 1/12/2024SG Americas Securities LLC12,337$135K0.0%N/A0.031% (Data available from 1/1/2016 forward) THRD Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of THRD shares? During the previous two years, the following institutional investors and hedge funds held shares of Third Harmonic Bio shares: Goldman Sachs Group Inc. ($548K), and FNY Investment Advisers LLC ($315K), SG Americas Securities LLC ($124K).Learn more on Third Harmonic Bio's institutional investors. What percentage of Third Harmonic Bio's stock is owned by institutional investors? 93.95% of Third Harmonic Bio's stock is owned by institutional investors. Learn more on THRD's institutional investor holdings. Which institutional investors have been buying Third Harmonic Bio's stock? The following institutional investors have purchased Third Harmonic Bio's stock in the last 24 months: FNY Investment Advisers LLC ($91.05K), Goldman Sachs Group Inc. ($51.31K), and SG Americas Securities LLC ($24.18K). How much institutional buying is happening at Third Harmonic Bio? Institutional investors have bought a total of 146,445 shares in the last 24 months. This purchase volume represents approximately $555.05K in transactions. Which of Third Harmonic Bio's major shareholders have been selling company stock? The following institutional investors have sold Third Harmonic Bio stock in the last 24 months: SG Americas Securities LLC ($12.13K). How much institutional selling is happening at Third Harmonic Bio? Institutional investors have sold a total of 12,133 shares in the last 24 months. This volume of shares sold represents approximately $144.79K in transactions. Related Companies NeoGenomics Institutional Ownership Spyre Therapeutics Institutional Ownership Arcus Biosciences Institutional Ownership Mineralys Therapeutics Institutional Ownership Nurix Therapeutics Institutional Ownership Pharvaris Institutional Ownership Praxis Precision Medicines Institutional Ownership Oric Pharmaceuticals Institutional Ownership MiMedx Group Institutional Ownership Oculis Institutional Ownership This page (NASDAQ:THRD) was last updated on 7/4/2025 by MarketBeat.com Staff From Our PartnersElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredRevealed: NEW A.I. revolution (nobody is talking about)Nvidia's CEO says this is: "The next wave of A.I." We're at the cusp of a new "A.I. Upgrade" that is set to...Behind the Markets | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | SponsoredGold: Now legal tender in many statesThe perfect gold play right now? (currently under $10) Everything in the news now lines up perfectly for an...Stansberry Research | SponsoredTrump's ticking time bombA looming tariff deadline on July 9th could be the spark — but what’s buried inside a recent White House docum...Porter & Company | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Third Harmonic Bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Third Harmonic Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
